Type 1 diabetes trials in Finland

In Finland 9 Also abroad 539

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Oulu, Tampere, Turku
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Helsinki, Oulu, Tampere, Turku
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
Phase 2Not yet taking people in Finland
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
Where
Helsinki, Turku
Age
18 years to 64 years
People
36 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06072326 · EU 2026-525684-40-01
No phaseTaking people
The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment
Where
Espoo, Helsinki
Age
7 years to 16 years
People
100
Run by
Helsinki University Central Hospital
See details and how to joinNCT07423637
Phase 2Taking people
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Where
Helsinki, Turku
Age
5 years to 40 years
People
159 worldwide
Run by
SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Helsinki
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
No phaseEnrolling by invitation
FinnDiane LifeOne Study - Impact of Ageing on People With Type 1 Diabetes
Where
Helsinki
Age
65 years and over
People
400
Run by
Helsinki University Central Hospital
See details and how to joinNCT07289204
No phaseTaking people
Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics
Where
Turku
Age
18 years to 45 years
People
60
Run by
Turku University Hospital
See details and how to joinNCT06343974
No phaseTaking people
TrialNet Pathway to Prevention of T1D
Where
Turku
Age
2 years to 45 years
People
75,000 worldwide
Run by
University of South Florida
See details and how to joinNCT00097292